RNU7-105P

Across TCGA pan-cancer cohorts, RNU7-105P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU7-105P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU7-105P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-105P expression acts as an unfavorable survival marker.

ACC, CESC, and LUSC are the cancer types where RNU7-105P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.113	0.822	<.001	63	view →
CESC	OS	Tertile	IV	0.091	0.593	<.001	36	view →
LUSC	DFS	Tertile	II,III,IV	0.135	0.663	.015	36	view →
GBM	OS	Tertile	All	0.076	0.415	<.001	18	view →
BLCA	DFS	Tertile	III,IV	0.159	0.572	.036	9	view →
LIHC	OS	Tertile	All	0.169	0.669	.032	9	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU7-105P–ACC (OS)

Open the ACC breakdown →